CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. (CBAY) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
cbay · market cap & enterprise value · FMP · as of Mar 21, 2024
Core market cap & key metrics
As of Mar 21, 2024, CymaBay Therapeutics, Inc. (CBAY) has a market cap — also referred to as its net worth or valuation — of $3.7B, making it one of the top most valuable companies globally. Market Cap = $32.48 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
CymaBay Therapeutics, Inc. (CBAY) has a market cap — also referred to as its net worth or valuation — of $3.7B as of Mar 21, 2024, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
CymaBay Therapeutics, Inc. reached its all-time high market cap of $2.5B on Dec 31, 2023. Comparing the CymaBay Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare CymaBay Therapeutics, Inc. net worth vs peers and ask how CymaBay Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
CBAY market cap · 6 questionsCymaBay Therapeutics, Inc.'s net worth — measured as market capitalization — is $3.7B as of Mar 21, 2024. It ranks #0 globally. Market Cap = $$32.48 (price) × shares outstanding.